Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950123-10-013000
Filing Date
2010-02-16
Accepted
2010-02-16 12:57:39
Documents
2
Group Members
ARNOLD L. ORONSKYBRUCE A. CLEVELANDCHRISTOPHER B. EHRLICHDOUGLAS A. PEPPERGILBERT H. KLIMANHARVEY B. CASHINTERWEST MANAGEMENT PARTNERS IX, LLCKHALED A. NASRLINDA S. GRAISMICHAEL B. SWEENEYNINA S. KJELLSONPHILIP T. GIANOSTHOMAS L. ROSCHW. STEPHEN HOLMES II

Document Format Files

Seq Description Document Type Size
1 SC 13G f54927bsc13g.htm SC 13G 231476
2 EX-99.A f54927bexv99wa.htm EX-99.A 17698
  Complete submission text file 0000950123-10-013000.txt   251787
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-51477 | Film No.: 10605420
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025
Business Address 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025 650-854-8585
InterWest Partners IX, LP (Filed by) CIK: 0001398928 (see all company filings)

EIN.: 202312479 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G